ConductScience.org, home

Paper11960331

Elucidating critical mechanisms of deregulated stem cell turnover in the chronic phase of chronic myeloid leukemia.

Holyoake TL and 4 others. Leukemia, 2002. Cited by 100 papers, by iCite.

Cite this record

ConductScience Library. Elucidating critical mechanisms of deregulated stem cell turnover in the chronic phase of chronic myeloid leukemia. Papers, record 11960331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11960331

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Elucidating critical mechanisms of deregulated stem cell turnover in the chronic phase of chronic myeloid leukemia.
PubMed
Journal
Leukemia
PubMed
Year
2002
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
100
iCite
Relative citation ratio, by iCite
1.59
iCite
Revised in PubMed
2026-10-10
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Holyoake TLT L
2Jiang XX
3Drummond MWM W
4Eaves ACA C
5Eaves CJC J

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hematopoietic Stem CellsMajor topic
Leukemia, Myelogenous, Chronic, BCR-ABL PositiveMajor topic
Adolescent
Adult
Aged
Aged, 80 and over
Antigens, CD
Cell Division
Chromosome Aberrations
Fusion Proteins, bcr-abl
Hematopoiesis
Humans
Middle Aged
Telomere

Source PubMed

Download CSV of topics

References92

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110733485Selective elimination of leukemic CD34(+) progenitor cells by cytotoxic T lymphocytes specific for WT1.Blood2000https://conductscience.org/library/papers/10733485PubMed
210905245Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells.Lancet2000https://conductscience.org/library/papers/10905245PubMed
314074844PERSISTENT MITOSIS OF TRANSFUSED HOMOLOGOUS LEUKOCYTES IN CHILDREN RECEIVING ANTILEUKEMIC THERAPY.Science1963https://conductscience.org/library/papers/14074844PubMed
48102237Targeted in vivo infection with a retroviral vector carrying the interleukin-3 (multi-CSF) gene leads to immortalization and leukemic transformation of primitive hematopoietic progenitor cells.Growth Factors1993https://conductscience.org/library/papers/8102237PubMed
511157490
Primitive quiescent leukemic cells from patients with chronic myeloid leukemia spontaneously initiate factor-independent growth in vitro in association with up-regulation of expression of interleukin-3.
Blood2001https://conductscience.org/library/papers/11157490PubMed
610865977Autonomous multi-lineage differentiation in vitro of primitive CD34+ cells from patients with chronic myeloid leukemia.Leukemia2000https://conductscience.org/library/papers/10865977PubMed
72890277The use of cell markers in the study of human hematopoietic neoplasia.Adv Cancer Res1987https://conductscience.org/library/papers/2890277PubMed
83422181Discordant maturation as the primary biological defect in chronic myelogenous leukemia.Cancer Res1988https://conductscience.org/library/papers/3422181PubMed
97026904Philadelphia chromosome positive blood B lymphocytes in chronic myelocytic leukemia.Leuk Res1981https://conductscience.org/library/papers/7026904PubMed
102408149Tyrosine kinase activity and transformation potency of bcr-abl oncogene products.Science1990https://conductscience.org/library/papers/2408149PubMed
111518302Granulocyte-macrophage colony-stimulating factor modulation of the inhibitory effect of transforming growth factor-beta on normal and leukemic human hematopoietic progenitor cells.Leukemia1992https://conductscience.org/library/papers/1518302PubMed
1214084628THE DISTRIBUTION OF THE PHILADELPHIA CHROMOSOME IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA.Blood1963https://conductscience.org/library/papers/14084628PubMed
1310432279Telomere fluorescence measurements in granulocytes and T lymphocyte subsets point to a high turnover of hematopoietic stem cells and memory T cells in early childhood.J Exp Med1999https://conductscience.org/library/papers/10432279PubMed
149345054The tyrosine kinase inhibitor CGP57148B selectively inhibits the growth of BCR-ABL-positive cells.Blood1997https://conductscience.org/library/papers/9345054PubMed
154126434Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining.Nature1973https://conductscience.org/library/papers/4126434PubMed
1611309493Structure-based design of selective and potent G quadruplex-mediated telomerase inhibitors.Proc Natl Acad Sci U S A2001https://conductscience.org/library/papers/11309493PubMed
1710477735Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia.Blood1999https://conductscience.org/library/papers/10477735PubMed
189299869New insights in biology and current therapeutic options for patients with chronic myelogenous leukemia.Haematologica1997https://conductscience.org/library/papers/9299869PubMed
199670051The fluctuating phenotype of the lymphohematopoietic stem cell with cell cycle transit.J Exp Med1998https://conductscience.org/library/papers/9670051PubMed
209501072Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span.Curr Biol1998https://conductscience.org/library/papers/9501072PubMed

See all 92 referencesDownload CSV of references

Cited by43

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 100 citations.

PMIDTitleJournalYearIn PapersSource
41816837Management of chronic myeloid leukemia with tyrosine kinase inhibitors: adverse events, toxicities and therapy dosing.Haematologica2026https://conductscience.org/library/papers/41816837PubMed
41179655Targeting the N-cadherin/β-catenin axis with MSAB reverses malignant phenotypes in blast crisis of CML.Front Oncol2025https://conductscience.org/library/papers/41179655PubMed
35058359Cell-free DNA profiling informs all major complications of hematopoietic cell transplantation.Proc Natl Acad Sci U S A2022https://conductscience.org/library/papers/35058359PubMed
30816504Adipose‑derived mesenchymal stem cells exhibit tumor tropism and promote tumorsphere formation of breast cancer cells.Oncol Rep2019https://conductscience.org/library/papers/30816504PubMed
30428386A Prospective Analysis of Human Leukemogenesis.Stem Cell Reports2018https://conductscience.org/library/papers/30428386PubMed
30344703Overexpression of miR-574-3p suppresses proliferation and induces apoptosis of chronic myeloid leukemia cells via targeting IL6/JAK/STAT3 pathway.Exp Ther Med2018https://conductscience.org/library/papers/30344703PubMed
30320108The Ins and Outs of Autophagy and Metabolism in Hematopoietic and Leukemic Stem Cells: Food for Thought.Front Cell Dev Biol2018https://conductscience.org/library/papers/30320108PubMed
29030909Global gene expression profiles of hematopoietic stem and progenitor cells from patients with chronic myeloid leukemia: the effect of in vitro culture with or without imatinib.Cancer Med2017https://conductscience.org/library/papers/29030909PubMed
28920078NOTCH1 Activation Depletes the Pool of Side Population Stem Cells in ATL.J Cancer Sci2017https://conductscience.org/library/papers/28920078PubMed
28725653CALR-positive myeloproliferative disorder in a patient with Ph-positive chronic myeloid leukemia in durable treatment-free remission: a case report.Stem Cell Investig2017https://conductscience.org/library/papers/28725653PubMed
28457753Expression of CD25 on leukemic stem cells in BCR-ABL1+ CML: Potential diagnostic value and functional implications.Exp Hematol2017https://conductscience.org/library/papers/28457753PubMed
27764087Optimized Treatment Schedules for Chronic Myeloid Leukemia.PLoS Comput Biol2016https://conductscience.org/library/papers/27764087PubMed
26833122The Cancer Stem Cell Fraction in Hierarchically Organized Tumors Can Be Estimated Using Mathematical Modeling and Patient-Specific Treatment Trajectories.Cancer Res2016https://conductscience.org/library/papers/26833122PubMed
24603533A 'telomere-associated secretory phenotype' cooperates with BCR-ABL to drive malignant proliferation of leukemic cells.Leukemia2014https://conductscience.org/library/papers/24603533PubMed
23349932Tumor cells positive and negative for the common cancer stem cell markers are capable of initiating tumor growth and generating both progenies.PLoS One2013https://conductscience.org/library/papers/23349932PubMed
23150808Gene Expression upon Proliferation and Differentiation of Hematopoietic Cells with Ph Chromosome ex vivo.Acta Naturae2012https://conductscience.org/library/papers/23150808PubMed
22751134Challenging the axiom: does the occurrence of oncogenic mutations truly limit cancer development with age?Oncogene2013https://conductscience.org/library/papers/22751134PubMed
22649623Cell Regulation of Proliferation and Differentiation ex vivo for Cells Containing Ph Chromosome in Chronic Myeloid Leukemia.Acta Naturae2009https://conductscience.org/library/papers/22649623PubMed
22237392Cancer stem cells: an evolving concept.Nat Rev Cancer2012https://conductscience.org/library/papers/22237392PubMed
21946665Chronic myeloid leukemia stem cells in the era of targeted therapies: resistance, persistence and long-term dormancy.Oncotarget2011https://conductscience.org/library/papers/21946665PubMed

See all 43 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABL125PubTator's text mininghttps://conductscience.org/library/genes/25NCBI Gene
CSF31440PubTator's text mininghttps://conductscience.org/library/genes/1440NCBI Gene
IL33562PubTator's text mininghttps://conductscience.org/library/genes/3562NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/11960331

GET https://conductscience.org/api/papers/v1/11960331/references?page=2